LTF and gastric cancer: By successfully conjugating lactoferrin with iron oxide nanoparticles, we achieved targeted delivery to gastric cancer cells, as lactoferrin is known to interact with proteoglycan, glycosaminoglycan, and sialic acid, which are present on the surface of cancer cells.